Guggenheim Upgrades GlaxoSmithKline (GSK) to Buy, ‘Vaccines, HIV, I&I, AND Oncology Set Up Improved 2024+ Growth’

Visit StreetInsider.com at http://www.streetinsider.com/Upgrades/Guggenheim+Upgrades+GlaxoSmithKline+%28GSK%29+to+Buy%2C+%27Vaccines%2C+HIV%2C+I%26I%2C+AND+Oncology+Set+Up+Improved+2024%2B+Growth%27/22874069.html for the full story.